Realtime VCS Test Statistics

Date of first VCS test:  Tue Jan 7 12:44:06 2014 (EST)
Date of most recent VCS test:  Sun Feb 19 05:05:02 2017 (EST)
Time site in operation:  1138.8 days

Tests with POSITIVE results (suggesting neurotoxin exposure is likely):  70.4%
Tests with NEGATIVE results (suggesting neurotoxin exposure is unlikely):  29.6%

Survey Statistics

Percentage of VCS test takers responding to at least 1 survey question:  79.7%

Percentage of VCS test takers self-rating their overall health on a scale of 1-10 (10 being highest/best):  78.9%
   Average self-rated overall health among all respondents:  5.78
   Average self-rated overall health among respondents with POSITIVE test results:  5.68
   Average self-rated overall health among respondents with NEGATIVE test results:  6.03

Percentage of VCS test takers who responded regarding recent mold exposure or suspected mold exposure:  78.1%
   Percentage reporting recent mold exposure or suspected mold exposure:  58.6%
      With POSITIVE test results:  72.2%
      With NEGATIVE test results:  27.8%
   Percentage reporting NO recent mold exposure or suspected mold exposure:  41.4%
      With POSITIVE test results:  68.2%
      With NEGATIVE test results:  31.8%

Percentage of VCS test takers who responded regarding mold illness diagnosis:  45.9%
   Percentage reporting mold illness diagnosis:  20.3%
      With POSITIVE test results:  70.3%
      With NEGATIVE test results:  29.7%
   Percentage reporting NO mold illness diagnosis:  79.7%
      With POSITIVE test results:  72.5%
      With NEGATIVE test results:  27.5%

Percentage of VCS test takers who responded regarding exposures to other neurotoxins:  77.5%
   Percentage reporting exposure to other neurotoxins:  38.1%
      With POSITIVE test results:  71.4%
      With NEGATIVE test results:  28.6%
   Percentage reporting NO exposure to other neurotoxins:  61.9%
      With POSITIVE test results:  69.9%
      With NEGATIVE test results:  30.1%

Percentage of VCS test takers who responded regarding diagnosis with exposure to other neurotoxins:  29.8%
   Percentage reporting diagnosis with exposure to other neurotoxins:  31.5%
      With POSITIVE test results:  70%
      With NEGATIVE test results:  30%
   Percentage reporting NO diagnosis with exposure to other neurotoxins:  68.5%
      With POSITIVE test results:  71.5%
      With NEGATIVE test results:  28.5%

Percentage of VCS test takers who responded regarding other conditions involving neurological function:  77.6%
   Percentage reporting suffering from a condition involving neurological function:  28.9%
      With POSITIVE test results:  70.6%
      With NEGATIVE test results:  29.4%
   Percentage reporting suffering from NO condition involving neurological function:  71.1%
      With POSITIVE test results:  70.5%
      With NEGATIVE test results:  29.5%